Once retatrutide is approved, well be ready to help you explore this exciting new option, too
Safety considerations patients should know The FDA has warned about multiple risks tied to compound semaglutide sold for weight loss, including products labeled with nonexistent pharmacies, dosing mistakes from multi-dose vials, and formulations made with semaglutide salts (e.g., acetate or sodium) rather than the approved basedifferences that may affect safety and legality
Rapid weight loss associated with semaglutide use may lead to changes in skin texture, hydration status, and barrier function
Take steps to soothe emotions if it's not true hunger
For more insight into how our research team vets, qualifies, and ranks providers, review our full methodology here